282 related articles for article (PubMed ID: 25039920)
1. Secretory Leukocyte Protease Inhibitor (SLPI) expression downregulates E-cadherin, induces β-catenin re-localisation and triggers apoptosis-related events in breast cancer cells.
Rosso M; Lapyckyj L; Amiano N; Besso MJ; Sánchez M; Chuluyan E; Vazquez-Levin MH
Biol Cell; 2014 Sep; 106(9):308-22. PubMed ID: 25039920
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
[TBL] [Abstract][Full Text] [Related]
3. [Correlation among expression of E-cadherin, beta-catenin, and cyclin D1 in breast cancers].
Yang JF; Chen SL; Liu ZH; Zhang Y
Ai Zheng; 2004 Jul; 23(7):799-802. PubMed ID: 15248915
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis of epithelial cadherin and related proteins in IBH-6 and IBH-4 human breast cancer cell lines.
Lapyckyj L; Castillo LF; Matos ML; Gabrielli NM; Lüthy IA; Vazquez-Levin MH
J Cell Physiol; 2010 Mar; 222(3):596-605. PubMed ID: 19957299
[TBL] [Abstract][Full Text] [Related]
5. [Effects of hFRNK on E-cadherin/beta-catenin in colon cancer cells in vitro].
Cao J; Yu JP; Liu CH; Chen XW; Liu S; Luo HS; Yu HG
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):346-50. PubMed ID: 17892129
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of β-catenin decreases the tumorigenicity, but promotes epithelial-mesenchymal transition in breast cancer cells.
Cai K; Jiang L; Wang J; Zhang H; Wang X; Cheng D; Dou J
J Cancer Res Ther; 2014; 10(4):1063-70. PubMed ID: 25579555
[TBL] [Abstract][Full Text] [Related]
7. Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells.
Sommers CL; Gelmann EP; Kemler R; Cowin P; Byers SW
Cancer Res; 1994 Jul; 54(13):3544-52. PubMed ID: 8012979
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor effect of SLPI on mammary but not colon tumor growth.
Amiano NO; Costa MJ; Reiteri RM; Payés C; Guerrieri D; Tateosian NL; Sánchez ML; Maffia PC; Diament M; Karas R; Orqueda A; Rizzo M; Alaniz L; Mazzolini G; Klein S; Sallenave JM; Chuluyan HE
J Cell Physiol; 2013 Feb; 228(2):469-75. PubMed ID: 22767220
[TBL] [Abstract][Full Text] [Related]
9. Soy isoflavone genistein upregulates epithelial adhesion molecule E-cadherin expression and attenuates beta-catenin signaling in mammary epithelial cells.
Su Y; Simmen RC
Carcinogenesis; 2009 Feb; 30(2):331-9. PubMed ID: 19073877
[TBL] [Abstract][Full Text] [Related]
10. Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells.
Vizirianakis IS; Chen YQ; Kantak SS; Tsiftsoglou AS; Kramer RH
Int J Oncol; 2002 Jul; 21(1):135-44. PubMed ID: 12063560
[TBL] [Abstract][Full Text] [Related]
11. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines.
Yang SZ; Kohno N; Yokoyama A; Kondo K; Hamada H; Hiwada K
Int J Oncol; 2001 Mar; 18(3):541-8. PubMed ID: 11179484
[TBL] [Abstract][Full Text] [Related]
12. [Effect of forced E-cadherin expression on adhesion and proliferation of human breast carcinoma cells].
Yang LJ; Liu YQ; Gu B; Bian XC; Feng HL; Yang ZL; Liu YY
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):842-7. PubMed ID: 21215101
[TBL] [Abstract][Full Text] [Related]
13. Overexpression and pre-treatment of recombinant human Secretory Leukocyte Protease Inhibitor (rhSLPI) reduces an in vitro ischemia/reperfusion injury in rat cardiac myoblast (H9c2) cell.
Prompunt E; Nernpermpisooth N; Sanit J; Kumphune S
Biomol Concepts; 2018 May; 9(1):17-32. PubMed ID: 29729136
[TBL] [Abstract][Full Text] [Related]
14. Restoration of E-cadherin/beta-catenin expression in pancreatic cancer cells inhibits growth by induction of apoptosis.
Lowy AM; Knight J; Groden J
Surgery; 2002 Aug; 132(2):141-8. PubMed ID: 12219004
[TBL] [Abstract][Full Text] [Related]
15. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
Lim SC; Lee MS
Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
[TBL] [Abstract][Full Text] [Related]
16. Par-4 dependent modulation of cellular β-catenin by medicinal plant natural product derivative 3-azido Withaferin A.
Amin H; Nayak D; Ur Rasool R; Chakraborty S; Kumar A; Yousuf K; Sharma PR; Ahmed Z; Sharma N; Magotra A; Mukherjee D; Kumar LD; Goswami A
Mol Carcinog; 2016 May; 55(5):864-81. PubMed ID: 25969134
[TBL] [Abstract][Full Text] [Related]
17. The alarm anti-protease, secretory leukocyte protease inhibitor, is a proliferation and survival factor for ovarian cancer cells.
Simpkins FA; Devoogdt NM; Rasool N; Tchabo NE; Alejandro EU; Kamrava MM; Kohn EC
Carcinogenesis; 2008 Mar; 29(3):466-72. PubMed ID: 17916899
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts.
Kuphal F; Behrens J
Exp Cell Res; 2006 Feb; 312(4):457-67. PubMed ID: 16368435
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation.
Yuan Z; Wong S; Borrelli A; Chung MA
Biochem Biophys Res Commun; 2007 Oct; 362(3):740-6. PubMed ID: 17764657
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.
Påhlman LI; Jögi A; Gram M; Mori M; Egesten A
BMC Pulm Med; 2015 Mar; 15():19. PubMed ID: 25851169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
